Full-Time

Senior IT Support Analyst

Updated on 9/4/2026

Beeline Medicines

Beeline Medicines

51-200 employees

Clinical-stage biotech developing precision autoimmune therapies

Compensation Overview

$102k - $133k/yr

+ Annual bonus + Long-term incentive award + Equity

Stamford, CT, USA

In Person

Fully on-site Monday through Friday; minimal to occasional travel may be required between offices or to support remote sites/end users.

Bachelor's

Category
IT Operations (1)
Required Skills
Inventory Management
Microsoft Intune

Get referred to Beeline Medicines

See people who can refer or advise you

Requirements
  • A bachelor's degree in Information Technology, Computer Science, or a related discipline, or equivalent years of industry experience.
  • At least 5 years of hands-on IT support experience, including desktop support, AV/event technology, and end-user troubleshooting.
  • Experience setting up and operating AV equipment for executive-level meetings and events, including conference room systems, webcasting, video conferencing, microphones, displays, and streaming technology.
  • Experience with Microsoft 365 applications and basic administration, including account management, Entra ID, Intune, and Autopilot.
  • Experience supporting Windows 10/11 and macOS desktops, including troubleshooting and imaging.
  • Experience with AV and event production, including conference room systems, webcasting equipment, video conferencing, streaming, and live event production.
  • Experience providing direct technology support to senior executives in a corporate office environment.
  • Professional executive-facing presence when working directly with C-suite leaders, board members, and external investors.
  • Experience supporting investor relations or corporate communications events, including earnings calls, investor presentations, or board meetings.
  • Ability to complete assigned work on time without reminders.
  • Ability to write accurate ticket notes and follow established procedures.
  • Ability to use a computer keyboard and monitor for extended periods, occasionally lift computer equipment weighing up to 25–50 pounds, and bend, kneel, or reach to install or troubleshoot hardware under desks or in server racks.
Responsibilities
  • Provide first- and second-level IT support for office-based employees by troubleshooting and configuring hardware, software, network connectivity, printing, and Microsoft 365 application issues.
  • Resolve tickets within established service-level agreements and escalate issues beyond scope to the Senior Manager or managed service provider service desk.
  • Document all support activity in the IT service management ticketing system.
  • Provide white-glove desktop and technology support to C-suite executives, including priority response, workstation setup, home-office technology configuration, and travel technology preparation.
  • Serve as the on-site technology point of contact for executive leadership, visiting board members, and other key stakeholders.
  • Ensure executives have working and tested technology before meetings, presentations, and external engagements.
  • Set up and operate AV equipment for earnings webcasts, investor days, board presentations, analyst meetings, and company town halls.
  • Run rehearsals, manage run-of-show technology, monitor live feeds, troubleshoot issues in real time, and break down equipment after events.
  • Coordinate with external AV vendors and webcast providers when events exceed in-house production capability.
  • Support off-site investor events and dinners with portable AV and connectivity solutions.
  • Maintain conference room technology, including Teams Rooms systems, displays, cameras, microphones, and wireless presentation devices.
  • Perform regular checks and preventive maintenance to keep office technology operational.
  • Set up temporary or overflow meeting spaces for board visits and investor days.
  • Manage guest Wi-Fi access, loaner devices, and visitor connectivity for external guests.
  • Coordinate hardware delivery to end users and manage office hardware and supplies.
  • Maintain inventory records for endpoints, peripherals, and conference room equipment, and track loaner devices.
  • Support account provisioning, password resets, multifactor authentication troubleshooting, group membership updates, and access requests according to established procedures.
  • Assist with requirements gathering and participate in hardware refreshes, office buildouts, technology deployments, equipment relocations, testing, and implementation activities.
  • Perform other assigned duties and responsibilities.

Beeline Medicines is a clinical-stage biotechnology company focused on precision therapies for autoimmune and inflammatory diseases, formed after in-licensing five programs from Bristol Myers Squibb with a $300 million Series A led by Bain Capital. Its lead programs include afimetoran, an oral lupus therapy that inhibits TLR7 and TLR8, lomedeucitinib, an allosteric TYK2 inhibitor, and two IND-stage biologics targeting IL-18 and IL-10 pathways. The drugs work by modulating specific immune signaling pathways to reduce inflammation, with afimetoran designed to address lupus drivers. The company differentiates itself by using in-licensed assets from a major pharma partner and combining them with an experienced leadership team to push multiple programs toward pivotal trials, starting with Phase 2 for afimetoran targeted for late 2026.

Company Size

51-200

Company Stage

Series A

Total Funding

$426.3M

Headquarters

Stamford, Connecticut

Founded

2025

Get referred to Beeline Medicines

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Beeline closed a $126.3 million extension on June 30, 2026, reaching $426.3 million.
  • FDA Fast Track for afimetoran in May 2025 accelerates regulatory interaction.
  • Management plans several clinical starts within 12 months, expanding catalysts beyond lupus.

What critics are saying

  • Afimetoran’s Phase 2 lupus readout in H2 2026 is the company’s make-or-break catalyst.
  • Failure versus Benlysta, Saphnelo, and competing lupus drugs kills the pivotal plan.
  • Five BMS-origin assets concentrate scientific risk; one bad readout can crush financing appetite.

What makes Beeline Medicines unique

  • BMS licensed five programs to Beeline in 2025, de-risking discovery.
  • Afimetoran targets TLR7/8, an upstream lupus mechanism unlike downstream cytokine biologics.
  • Saqib Islam and SpringWorks veterans bring repeatable biotech execution and exit experience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Paid Vacation

Paid Holidays

Health Insurance

Company Equity

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

-8%

1 year growth

-8%

2 year growth

-8%
Beeline Medicines
Jun 30th, 2026
Terms of Use - Beeline Medicines

Terms of Use Agreement Effective: April 8, 2026 1. Acceptance of the Terms and Conditions. Beeline Medicines Corporation (herein referred to as “Beeline,” “we,” “us” or “our”) provides and makes available this web site (the “Web Site”). All use of the Web Site is subject to the terms and conditions contained in this Terms of […]

Fierce Biotech
Jun 29th, 2026
BMS-backed Beeline raises $126M series A extension for autoimmune programs

Beeline Medicines has raised $126.3 million in a Series A extension, just two and a half months after emerging from stealth with $300 million in funding and five autoimmune programmes from Bristol Myers Squibb. The biotech startup, backed by BMS, is developing treatments targeting autoimmune diseases. The additional funding comes as the company rapidly advances its pipeline following its December debut. Details about the extension round's investors and the company's specific plans for the new capital were not disclosed.

Yahoo Finance
Apr 15th, 2026
Beeline debuts with $300M and immune drugs licensed from Bristol Myers

Beeline Medicines emerged from stealth with $300 million in Series A funding from Bain Capital to develop precision therapies for immune diseases. The company's pipeline includes five experimental medicines licensed from Bristol Myers Squibb nearly a year ago. Beeline's lead asset is afimetoran, a daily oral treatment for systemic lupus erythematosus targeting immune system receptors. A Phase 2 study is expected to complete in the second half of this year, with a pivotal programme planned thereafter. The pipeline also includes candidates for atopic dermatitis, lupus and plaque psoriasis, plus two preclinical assets. Saqib Islam, former CEO of SpringWorks Therapeutics, leads the company. Bain Capital previously backed Cerevel Therapeutics, acquired by AbbVie for nearly $9 billion, and Aiolos Bio, purchased by GSK.

Dealroom.co
Apr 15th, 2026
Beeline Medicines company information, funding & investors

Beeline Medicines, precision therapies for autoimmune and inflammatory diseases. Here you'll find information about their funding, investors and team.

GlobeNewswire
Apr 15th, 2026
Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases

– Advancing a broad portfolio designed to deliver multiple paradigm-shifting therapies for devastating and underserved immune-mediated diseases –  – Lead...